ATE130102T1 - Verfahren zur identifizierung oder bestimmung von proteinen und verwendungen dazu. - Google Patents

Verfahren zur identifizierung oder bestimmung von proteinen und verwendungen dazu.

Info

Publication number
ATE130102T1
ATE130102T1 AT91430007T AT91430007T ATE130102T1 AT E130102 T1 ATE130102 T1 AT E130102T1 AT 91430007 T AT91430007 T AT 91430007T AT 91430007 T AT91430007 T AT 91430007T AT E130102 T1 ATE130102 T1 AT E130102T1
Authority
AT
Austria
Prior art keywords
proteins
identifying
determining
peptides
antibodies
Prior art date
Application number
AT91430007T
Other languages
English (en)
Inventor
Frederic Jean
Jacques Barbet
Michel Delaage
Original Assignee
Immunotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech Sa filed Critical Immunotech Sa
Application granted granted Critical
Publication of ATE130102T1 publication Critical patent/ATE130102T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
AT91430007T 1990-04-06 1991-04-04 Verfahren zur identifizierung oder bestimmung von proteinen und verwendungen dazu. ATE130102T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9004774A FR2660757B1 (fr) 1990-04-06 1990-04-06 Procede d'identification ou de dosage de proteines et applications.

Publications (1)

Publication Number Publication Date
ATE130102T1 true ATE130102T1 (de) 1995-11-15

Family

ID=9395750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91430007T ATE130102T1 (de) 1990-04-06 1991-04-04 Verfahren zur identifizierung oder bestimmung von proteinen und verwendungen dazu.

Country Status (8)

Country Link
US (1) US5449601A (de)
EP (1) EP0451070B1 (de)
JP (1) JP3070773B2 (de)
AT (1) ATE130102T1 (de)
DE (1) DE69114339T2 (de)
ES (1) ES2079621T3 (de)
FR (1) FR2660757B1 (de)
GR (1) GR3018371T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054055A1 (de) * 2000-10-31 2002-05-23 Nmi Univ Tuebingen Verfahren zur Analyse von Proteinen
US20030092008A1 (en) * 2001-11-14 2003-05-15 Bell Michael L. Method and apparatus for multiplex flow cytometry analysis of diverse mixed analytes from bodily fluid samples
US7618788B2 (en) * 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US20060014212A1 (en) * 2002-05-10 2006-01-19 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
JP2006511819A (ja) * 2002-05-10 2006-04-06 イピトミ バイオシステムズ インコーポレイテッド ユニーク認識配列及びタンパク質分析におけるその利用方法
US7460960B2 (en) * 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
WO2005050224A2 (en) * 2003-11-13 2005-06-02 Epitome Biosystems Inc. Small molecule and peptide arrays and uses thereof
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
SI2691530T1 (en) 2011-06-10 2018-08-31 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7802056A (nl) * 1977-03-14 1978-09-18 Hoffmann La Roche Bepaling van menselijk (beta)-lipotropine.
ATE23169T1 (de) * 1983-07-21 1986-11-15 Scripps Clinic Res Synthetische polypeptide, die gehirnspezifischen mrnas translatierten proteinoidabschnitten entsprechen, sowie ihre anwendung fuer rezeptoren, methoden und diagnostik.
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4795702A (en) * 1986-02-05 1989-01-03 Immunogon Associates Diagnostic method for gonorrhea by assay of IgA1 fragments
WO1987007957A1 (en) * 1986-06-20 1987-12-30 The Regents Of The University Of California Low-level detection of human immunodeficiency virus
EP0345906B1 (de) * 1988-06-10 1996-03-13 Merck & Co. Inc. Antigene der einzigen Spaltungsstelle von Fibrinogen durch Elastase

Also Published As

Publication number Publication date
DE69114339T2 (de) 1996-05-30
US5449601A (en) 1995-09-12
ES2079621T3 (es) 1996-01-16
JP3070773B2 (ja) 2000-07-31
FR2660757B1 (fr) 1994-05-27
JPH05240855A (ja) 1993-09-21
EP0451070A1 (de) 1991-10-09
DE69114339D1 (de) 1995-12-14
FR2660757A1 (fr) 1991-10-11
GR3018371T3 (en) 1996-03-31
EP0451070B1 (de) 1995-11-08

Similar Documents

Publication Publication Date Title
ATE130102T1 (de) Verfahren zur identifizierung oder bestimmung von proteinen und verwendungen dazu.
DE69020143D1 (de) Verfahren zur verwendung und herstellung von peptiden.
ATE159982T1 (de) Antikörper mit modifiziertem kohlenhydratgehalt und verfahren zur herstellung und verwendung
DE3586402D1 (de) Proteinzusammensetzung mit koagulations-wirkung und verfahren zu ihrer herstellung.
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
DE3587875T3 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
DE3865963D1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
ATE366420T1 (de) Kit und verfahren zur bestimmung von protein esm- 1
ID19063A (id) Pereaksi peptida untuk deteksi cytomegalovirus (cmv)
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
DE3887750T2 (de) Selektive entfernung von immunkomplexen.
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE301671T1 (de) Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta
DE69927691D1 (de) Verfahren zur eiweissanalyse
ATE105086T1 (de) Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b.
ATE55059T1 (de) Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen.
DE3751249D1 (de) Protein L und ihre Untereinheiten, mit immunglobulinbindender Aktivität, Verfahren zur Herstellung, Reagenssatz, pharmazeutische Zubereitung und ein Peptococcus-magnus-Stamm.
DE69333992D1 (de) Verfahren zur herstellung eines sets von kombinatorischen polypeptidantigenen
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE3880122D1 (de) Verfahren zur solubilisierung von unloeslichem protein.
DE3783840D1 (de) Verfahren zur bestimmung von plasma-protein und testsatz dafuer.
ATE85087T1 (de) Verfahren zur bestimmung von plasma-protein und testsatz dafuer.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties